MedEx Research Staffing: Your source for technical and scientific employment.
CenterWatch: Subscribe to Research Practitioner
CenterWatch PI Guide

Webinars

April | May

April

April 28, 2014

Barnett International

Recent Trends in Noncompliance: Critical Review and Analysis of Recent Regulatory Letters and Communications from the FDA, EMA, and Health Canada

12:30 PM - 2:30 PM Eastern

As the clinical research environment evolves in response to both internal and external changes, regulatory agency communication appears to be focused on particular areas of GCP compliance. Regulatory agencies’ recent findings for Clinical Investigators, sponsors, and Institutional Review Boards (IRBs) tend to reflect historic areas of noncompliance; however, more attention is being placed on ensuring that corrective and preventive action plans are developed to secure compliance. This web seminar will examine the trends in recent regulatory communication and open discussion for review of acceptable versus unacceptable responses.

April 29, 2014

Barnett International

Fraud in Clinical Research: An Overview

12:30 PM - 2:30 PM Eastern

Fraudulent activities in clinical research undermine clinical research professionals’ ability to meet their obligations for ensuring credible data is obtained from protected participants. This web seminar provides an overview of fraud in clinical research and its potential impact on the industry and the public’s health.

April 30, 2014

Barnett International

Monitoring Reports: 10 Rules of Effective Report Writing

12:00 PM - 3:00 PM Eastern

The Clinical Research Associate (CRA) creates reports that have many audiences, one being regulatory authorities reviewing essential documentation of clinical trials linked to marketing application approvals. This web seminar presents 10 categories of scientific report writing in the context of the role of the CRA and the reports that they write. The applicable reports are monitoring visit reports, e-mails, telephone reports, Memos to File, and more. The concepts of writing in a scientific voice versus first person, objective versus subjective, and many more are presented. This course is invaluable for the CRA, as well as the individual who critiques the various reports.

April 30, 2014

Barnett International

Final AE Regulatory Guidance: Reporting/Communication of Safety Information from Clinical Trials to IRBs

12:00 PM - 1:30 PM Eastern

This web seminar presents content and impact discussion of the FDA and Office of Human Research Protections (OHRP) Adverse Event reporting guidance documents. The guidance documents address issues of Adverse Event information exchange between stakeholders and propose solutions to the issues of the quality of information being sent to the IRBs. The guidance impacts the activities of the research site, IRB, and sponsor/CRO’s role in compiling and/or communicating Adverse Event information during a research study, changing the industry’s current practices.

April 30, 2014

Barnett International

Preparing for SOP Inspection: An Auditor's Perspective

2:00 PM - 3:30 PM Eastern

Standard Operating Procedures (SOPs) are defined as detailed, written instructions that permit processes to be executed uniformly. In an effort to ensure compliance with regulations and guidelines, many sponsors, CROs, and clinical research sites have developed and incorporated SOPs into their operations. Too often, however, these documents are not reviewed critically and with enough frequency to make certain the information they convey is accurate and acceptable. Although training of staff and assessment of comprehension and compliance are crucial to implementation, the content and structure of SOPs should be routinely audited to take full advantage of their purpose. In this web seminar, we will discuss approaches to evaluating SOPs to ensure they are current and compliant.

May

May 1, 2014

Barnett International

CRC Role/Responsibilities Training

1:00 PM - 3:00 PM Eastern

The Clinical Research Coordinator (CRC) can be a key liaison between the investigator, subject, Institutional Review Board (IRB), and sponsor. The CRC assists the investigator to ensure that the clinical trial is successfully implemented and completed. This web seminar presents the core skills and activities performed by the CRC and the documentation requirements that come along with clinical trials.

May 2, 2014

Barnett International

GCP Training for Investigators

12:30 PM - 3:30 PM Eastern

This web seminar provides a brief review of new drug development and the clinical trial process as it affects the investigator, and explains where Good Clinical Practice (GCP) fits in. Relevant sections of the Code of Federal Regulations (CFR), International Conference on Harmonization (ICH), and Form FDA 1572 are discussed in-depth and in relationship to the investigator’s responsibilities for proper conduct of clinical trials. This course will highlight the 13 principles of ICH GCP as the foundation for all clinical studies, and demonstrate to the investigator the rationale for sponsor requirements throughout clinical development of an investigational drug.

May 2, 2014

Barnett International

Design Considerations for GCP Training Programs

1:00 PM - 3:00 PM Eastern

Regulatory authority inspection trends are identifying a need for truly effective Good Clinical Practice (GCP) training. GCP training should ensure that clinical research stakeholders not only “know GCP” but know how to apply the principles of GCP in their work lives. The decision to develop and implement a GCP Training Program is a time-consuming and expensive project for any clinical research organization. How can you maximize the effectiveness of the training to ensure return on this investment in both financial and compliance terms? By designing GCP training with a focus on engaging adult learners, which is critical to ensuring both acceptance by the learners and the transfer of knowledge into everyday professional practice. This web seminar will identify key elements to consider throughout the phases of program development and design, training deployment, and post-course assessment.

May 5, 2014

Barnett International

Use of Notes to File in Clinical Trial Essential Documentation

8:30 AM - 10:00 AM Eastern

Notes to File (NTF), also known as Memo to File, are commonly used as essential documentation in sponsor and site files. Many times the content of the NTF does not serve the purpose for use or serves no purpose at all. This web seminar will discuss the appropriate and inappropriate uses of NTF, the questions to ask to determine if NTF would be beneficial, and the components of a quality NTF, if being used.

May 5, 2014

Barnett International

Corrective Action Plans: Essential Documentation of a Site's Response to GCP Deficiencies

12:00 PM - 1:30 PM Eastern

Non-compliance at research sites requires corrective action planning to address the deficiencies. The corrective action plan should include more than just the identification of the deficiency and intervention chosen to address the issue. Effective corrective action planning includes other important components that lead to promoting improved performance for future activities: Ultimately improved human subject protections and data integrity. Lack of these components can lead to repeated non-compliance and in some cases to rejection of corrective action plans by regulatory authorities.

May 5, 2014

Barnett International

HIPAA Team Training: Fundamental Training Specifically for Clinical Research Settings

12:00 PM - 3:00 PM Eastern

HIPAA Team Training has been designed as a course presenting concepts and terminology of HIPAA specific to conducting clinical trials. The web seminar presents the core elements with methodologies for blending the concepts into established clinical trial best practices. The focus of the course is to train sponsors/CROs and site clinical researchers HIPAA concepts for later application in day-to-day roles.

May 6, 2014

Barnett International

Study Site Start-Up: Organization and Management Tips for the Novice Clinical Research Site

12:00 PM - 2:30 PM Eastern

The role of the research site is vital in the success of a clinical trial. Quality research sites are in great demand in the current research environment. This web seminar presents an overview of the core components for a successful research site. Examples of successful sites for benchmarking will be included as well as resources for more information.

May 7, 2014

Barnett International

Monitoring Oncology Clinical Trials

1:00 PM - 3:00 PM Eastern

This web seminar will provide attendees with a general overview of oncology clinical trials and their distinct characteristics. We will review how oncology clinical trials differ from those in other therapeutic areas, with a special emphasis on the unique challenges of monitoring oncology clinical trials. Distinctions will be drawn between early and later phase trials. Attention will be paid to Adverse Event (AE) and Serious Adverse Event (SAE) reporting. All aspects of oncology clinical trials and how to successfully monitor them will also be discussed.

May 8, 2014

Barnett International

Clinical Trials and the Sunshine Act: The Effect on the Clinical Research Industry

9:30 AM - 11:00 AM Eastern

In an effort to increase transparency, highlight potential conflicts of interest, and ultimately decrease healthcare costs, one element of the Patient Protection and Affordable Care Act (PPACA) – the Sunshine Act – requires disclosure of payments or transfer of value to physicians. These physicians can also be involved in clinical research as Investigators, in which case additional information is required to be reported. Released in February 2013, the final rule requires applicable manufacturers of covered drugs, devices, and biological supplies to gather and report information to be listed on the public website. This web seminar will address the requirements for reporting of information derived from clinical research as well as exceptions for reporting.

May 8, 2014

Barnett International

Auditing Clinical Research Studies: An Overview for Assessing GCP Compliance

12:30 PM - 2:30 PM Eastern

Quality assurance is defined as a “systematic and independent examination of trial-related activities and documents” that allows an auditor to determine whether or not the clinical trial was conducted according to the regulations and guidance that govern clinical research. This web seminar will provide an overview of auditing skills and techniques and a review of recent GCP audit findings from Clinical Investigators (Sites), Sponsors, and Institutional Review Boards (IRBs).

May 9, 2014

Barnett International

Adverse Event Monitoring for CRAs

12:00 PM - 2:00 PM Eastern

During monitoring visits, one of the most important and impacting activities that a Clinical Research Associate (CRA) performs is the source document verification of Adverse Events (AEs). The CRA serves as the eyes for the research sponsor when it comes to proper collection and documentation of subject safety information. Incorrect and inadequate monitoring of AEs can lead to inaccurate labelling for clinical trials and impact market application inspectional reviews, as well as post marketing labelling. The safety, regulatory, and ICH definitions will be reviewed and applied to the monitoring process in this web seminar. This includes Causality, Expectedness/Unanticipated, and other important concepts. Case scenarios will be used to apply the information for better learning.

May 12, 2014

Barnett International

The CRA Role in Risk-Based Monitoring: Strategies for Effective Remote Monitoring

9:30 AM - 11:00 AM Eastern

Strategies for saving time and money, without compromising oversight and quality, are an ongoing challenge within the industry. In an age where technology is ever present from ordering medications online, consulting with a physician, and having “live” conversations in chat rooms about medical issues, the clinical research industry has been slow to maximize the use of technology. With sponsors/CROs implementing the FDA’s final guidance on a risk-based approach to monitoring, time on site is being reduced to one day visits and/or on-site visits are scheduled few and far between per monitoring plans. Better utilization of remote monitoring is critical to ensure sites are compliant and the data is accurate and consistent. During this web seminar, strategies for remote monitoring will be discussed, including the review of data for trends, how to make the most of writing queries, and what “red flags” to look for that may indicate issues on site.

May 12, 2014

Barnett International

Risk-Proof Your Sites: Monitoring Strategies for Managing Risks

1:00 PM - 3:00 PM Eastern

The concepts and processes of risk management are well known and often used in clinical research project management. Yet, few clinical research monitors realize the value of applying these activities to site management. This web seminar starts with an overview of risk assessment and management. The learner is then guided through the application of these techniques through all phases of study conduct: Site selection and initiation, routine monitoring, and site close-out. The course focuses on identification of site strengths and weaknesses and implementing strategies to address weaknesses before they lead to deviations or noncompliance.

May 13, 2014

Barnett International

FDA Drug Approval Process

12:30 PM - 3:30 PM Eastern

This web seminar provides an overview of what is required to take a new drug from research to market. We will begin by reviewing the contents of an IND, and then follow the process of an IND submission. From there, the contents and approval process of an NDA submission will be discussed. This web seminar will also provide a foundation for those who require an understanding of the FDA new drug approval process, and help attendees become familiar with the regulatory landscape in which INDs and NDAs are developed and approved.

May 13, 2014

Barnett International

Essential Documentation in Clinical Trials at Research Sites

1:00 PM - 3:00 PM Eastern

Essential documentation serves to demonstrate the compliance of the investigator, sponsor and monitor, and IRB with the standards of GCP, best practice, and all applicable regulatory requirements. This course will discuss various types of essential documentation, subject specific and non-subject specific, for both drug and device trial research sites. The course will help define what should be maintained at a research site to promote adequate and accurate documentation of site, monitor, and IRB performance.

May 14, 2014

Barnett International

Comparison of the FDA's Three Major Regulations: GCP, GLP, and GMP

12:30 PM - 3:30 PM Eastern

This web seminar presents an overview of the three major global regulations: GCP, GLP, and GMP. Although varying slightly in different regions of the world, these three major regulations have the same basic elements and interpretations globally. In this web seminar, we will discuss each regulation individually, as well as how they differ from one another. Participants will learn when the use of each regulation is necessary, and how these three regulations fit into the development process.

May 14, 2014

Barnett International

The European Pharmacovigilance Legislation

1:00 PM - 2:30 PM Eastern

In July 2012, pharmacovigilance legislation went into effect across the European Union (EU) as a result of changes set out in Regulation (EU) No1235/2010: and Directive 2010/84/EU. The legislation is underpinned by a European Commission (EC) Implementing Measures Regulation and a series of modules on Good Pharmacovigilance Practice. Are you confident your pharmacovigilance operations will meet the EU’s latest expectations for compliance? Do you understand the processes needed to perform adequate risk assessment?

May 14 - July 30, 2014 (Wednesday nights. No class July 2 or July 9.)

Barnett International

10-Week CRA & CRC Beginner Program

6:00 PM - 9:00 PM Eastern

The online 10-Week CRA & CRC Beginner Program provides a comprehensive introduction to clinical research and the job functions of the Clinical Research Associate (CRA) and Clinical Research Coordinator (CRC) for both drug/biologic and device trials. This program is geared toward individuals seeking a new career or career change into clinical research, but who don’t know which job track to pursue. Case studies and industry best practices are presented to underscore how the learning objectives apply directly to the responsibilities of the CRA and CRC. Upon completion, Barnett will provide resume assistance so that you can position yourself for entry into this market.

May 15, 2014

Barnett International

Quality Risk Management in Clinical Trials and Pharmacovigilance

12:00 PM - 1:30 PM Eastern

The ICH Q9 Quality Risk Management (QRM) guideline has become an accepted standard, facilitating the development and implementation of a systematic risk-based approach to quality management of clinical trials and pharmacovigilance. Industry and regulatory bodies, including the EMA and FDA, have recognized the need and benefits of implementing a risk-based approach to quality management.

May 15, 2014

Barnett International

Final FDA Guidance: How to Complete the FDA Form 1572, Adequately and Accurately

1:00 PM - 3:00 PM Eastern

Proper completion of the Statement of Investigator has been greatly debated. Many stakeholders differ in opinions on what is accurate and adequate in completing this form. For example, who should be listed as sub-investigators, do we need to complete a 1572 for certain projects, and so forth. This web seminar will review the 2010 FDA information sheet and answer many of the questions about how to properly complete the form. The course will also discuss what is still not clear even after the guidance and how to get the answers.